Market Updates, Products & Ingredients

Open Book Extracts Expands Capabilities to Boost Finished Products Manufacturing

Plans will address increased demand for the company’s product development and manufacturing services.

Open Book Extracts (OBX) has expanded operations and service capabilities for finished goods manufacturing to serve global customers more effectively. The new capabilities accelerate the pace of product innovation while significantly increasing the company’s manufacturing capacity and operational excellence, OBX said.

Highlights of the expansion at the company’s headquarters in North Carolina include the addition of commercial equipment for high output production of tinctures, gummies, and softgels, as well as packaging automation. This expansion significantly enhances OBX’s ability to deliver its clients premium finished products with reduced lead times, and most importantly, within specification. Commercial production utilizing the expanded capabilities began in April 2022 with a soft introduction and is now being offered on all product lines.

In support of the expansion, OBX has added over 30 new team members, including the following key hires:

Gabrielle Krupp: Krupp joins OBX as director of sales operations. She previously served as director of insider sales and key account management at Folium Biosciences, and in sales management at E. & J. Gallo Winery.

Walter Rogowski: Rogowski joins OBX as finished goods production manager. He brings over 20 years of progressive operational and manufacturing experience in plastic processing, medical device, and tobacco processing, and was most recently with Santa Fe Natural Tobacco, manufacturer of the American Spirit brand.

Additional key hires include Lakey Walker as master scheduler (formerly with Santa Fe Natural Tobacco, manufacturer of the American Spirit brand), Sara O’Neal as quality control scientist (RTI International), Lee Puryear as finished goods quality assurance specialist (formerly with Gloster), and Jonathan Wetzel as sales and customer service associate (GVB Biopharma).

“The expansion of our team and finished goods capabilities is our solution to rising supply chain delays and inconsistency,” said Dave Neundorfer, OBX chief executive officer. “This investment not only expands our customer-centric offerings to support future growth, but also builds upon our history of quality, customer service, and the realization of our corporate mission to make products that work for the brands that care.”

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters